<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Thu, 20 Aug 2026 20:52:26 -0400--><rss version="2.0">
    <channel>
        <title>IceCure Medical Ltd. (ICCM) Press Releases</title>
        <link>https://ir.icecure-medical.com/news-events/press-releases/rss</link>
        <description></description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/_54f40390b69697dace3343a57e47c1a7/icecuremedical/files/theme/images/logo-sm.png</url>
                <title>IceCure Medical Ltd. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[West Cancer Center Receives IRB Approval to Commence IceCure's ChoICE Study for Breast Cancer Cryoablation]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.icecure-medical.com/news-events/press-releases/detail/236/west-cancer-center-receives-irb-approval-to-commence-icecures-choice-study-for-breast-cancer-cryoablation</link>
                <pubDate>Thu, 20 Aug 26 08:10:00 -0400</pubDate>
                <guid>https://ir.icecure-medical.com/news-events/press-releases/detail/236/west-cancer-center-receives-irb-approval-to-commence-icecures-choice-study-for-breast-cancer-cryoablation</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[IceCure Highlights Two New Peer-Reviewed Publications Supporting Cryoablation in Breast Cancer Treatment De-Escalation]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.icecure-medical.com/news-events/press-releases/detail/235/icecure-highlights-two-new-peer-reviewed-publications-supporting-cryoablation-in-breast-cancer-treatment-de-escalation</link>
                <pubDate>Thu, 13 Aug 26 09:10:00 -0400</pubDate>
                <guid>https://ir.icecure-medical.com/news-events/press-releases/detail/235/icecure-highlights-two-new-peer-reviewed-publications-supporting-cryoablation-in-breast-cancer-treatment-de-escalation</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[IceCure Reports its Financial Results for the First Half of 2026 with 45% Revenue Growth Year-Over-Year]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.icecure-medical.com/news-events/press-releases/detail/234/icecure-reports-its-financial-results-for-the-first-half-of-2026-with-45-revenue-growth-year-over-year</link>
                <pubDate>Wed, 12 Aug 26 08:30:00 -0400</pubDate>
                <guid>https://ir.icecure-medical.com/news-events/press-releases/detail/234/icecure-reports-its-financial-results-for-the-first-half-of-2026-with-45-revenue-growth-year-over-year</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[IceCure Medical Adds Adventist Health as U.S. Clinical Site for its Post-Marketing "ChoICE" Study for Low-Risk Breast Cancer Cryoablation Treatment]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.icecure-medical.com/news-events/press-releases/detail/233/icecure-medical-adds-adventist-health-as-u-s-clinical-site-for-its-post-marketing-choice-study-for-low-risk-breast-cancer-cryoablation-treatment</link>
                <pubDate>Thu, 06 Aug 26 08:05:00 -0400</pubDate>
                <guid>https://ir.icecure-medical.com/news-events/press-releases/detail/233/icecure-medical-adds-adventist-health-as-u-s-clinical-site-for-its-post-marketing-choice-study-for-low-risk-breast-cancer-cryoablation-treatment</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[IceCure Medical to Report First Half 2026 Financial and Operating Results on August 12, 2026]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.icecure-medical.com/news-events/press-releases/detail/232/icecure-medical-to-report-first-half-2026-financial-and-operating-results-on-august-12-2026</link>
                <pubDate>Wed, 05 Aug 26 08:30:00 -0400</pubDate>
                <guid>https://ir.icecure-medical.com/news-events/press-releases/detail/232/icecure-medical-to-report-first-half-2026-financial-and-operating-results-on-august-12-2026</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.icecure-medical.com/news-events/press-releases/detail/231/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-guidelines-citing-icecures-fda-clearance-of-prosense</link>
                <pubDate>Wed, 29 Jul 26 08:25:00 -0400</pubDate>
                <guid>https://ir.icecure-medical.com/news-events/press-releases/detail/231/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-guidelines-citing-icecures-fda-clearance-of-prosense</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[IceCure Medical Kicks Off its Post-Marketing "ChoICE" Study for the Low-Risk Breast Cancer Treatment at First U.S Clinical Site]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.icecure-medical.com/news-events/press-releases/detail/230/icecure-medical-kicks-off-its-post-marketing-choice-study-for-the-low-risk-breast-cancer-treatment-at-first-u-s-clinical-site</link>
                <pubDate>Mon, 27 Jul 26 08:32:00 -0400</pubDate>
                <guid>https://ir.icecure-medical.com/news-events/press-releases/detail/230/icecure-medical-kicks-off-its-post-marketing-choice-study-for-the-low-risk-breast-cancer-treatment-at-first-u-s-clinical-site</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[IceCure Expands U.S. Commercial Team to Meet Surging Demand for ProSense® Cryoablation]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.icecure-medical.com/news-events/press-releases/detail/229/icecure-expands-u-s-commercial-team-to-meet-surging-demand-for-prosense-cryoablation</link>
                <pubDate>Tue, 14 Jul 26 08:32:00 -0400</pubDate>
                <guid>https://ir.icecure-medical.com/news-events/press-releases/detail/229/icecure-expands-u-s-commercial-team-to-meet-surging-demand-for-prosense-cryoablation</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[IceCure Highlights Expanding Commercial Adoption of ProSense™ Cryoablation in Brazil Following FDA Clearance for Breast Cancer]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.icecure-medical.com/news-events/press-releases/detail/228/icecure-highlights-expanding-commercial-adoption-of-prosense-cryoablation-in-brazil-following-fda-clearance-for-breast-cancer</link>
                <pubDate>Mon, 06 Jul 26 08:11:00 -0400</pubDate>
                <guid>https://ir.icecure-medical.com/news-events/press-releases/detail/228/icecure-highlights-expanding-commercial-adoption-of-prosense-cryoablation-in-brazil-following-fda-clearance-for-breast-cancer</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[IceCure Regains Compliance with Nasdaq Minimum Bid Price Requirement]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.icecure-medical.com/news-events/press-releases/detail/227/icecure-regains-compliance-with-nasdaq-minimum-bid-price-requirement</link>
                <pubDate>Thu, 25 Jun 26 08:12:00 -0400</pubDate>
                <guid>https://ir.icecure-medical.com/news-events/press-releases/detail/227/icecure-regains-compliance-with-nasdaq-minimum-bid-price-requirement</guid>
                                                                            </item>
            </channel>
</rss>